Interactions between cell death induced by statins and 7‐ketocholesterol in rabbit aorta smooth muscle cells
- 1 July 2008
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 154 (6) , 1236-1246
Abstract
Background and purpose: 7‐Ketocholesterol, an oxysterol present in atherosclerotic lesions, induces smooth muscle cell (SMC) death, thereby destabilizing plaques. Statins protect patients from myocardial infarction, though they induce SMC apoptosis. We investigated whether statins and 7‐ketocholesterol exerted additive cell death effects.Experimental approach: Cultured rabbit aorta SMCs (passage 2–6) were exposed to 7‐ketocholesterol with or without fluvastatin, simvastatin or pravastatin. Uptake of neutral red (NR), monolayer protein, cleavage of the pan‐caspase substrate Asp‐Glu‐Val‐Asp‐rhodamine110, cell morphology (light and electron microscopy) and processing of microtubule‐associated protein 1 light chain 3 (LC3, immunoblot) were determined.Key results: NR uptake declined upon 18 h exposure to 25 μM 7‐ketocholesterol (−41±3%, n=13), 100 μM fluvastatin (−59%) or 30–100 μM simvastatin (−28 to −74%). Oxysterol and high statin concentrations exerted additive effects, but lower concentrations (fluvastatin 10–30 μM, simvastatin 1–10 μM) partly reversed viability loss. 7‐Ketocholesterol caused intense cytoplasmic vacuolization, processing of LC3‐I to LC3‐II, but little caspase activation (increase 29.5%). Fluvastatin (10–100 μM, 70–545% increase) and simvastatin (3–100 μM 43–322% increase) induced caspase activation without LC3 processing, but failed to activate caspases in 7‐ketocholesterol‐treated SMCs. Pravastatin up to 100 μM was always inactive.Conclusions and implications: 7‐Ketocholesterol caused SMC death, mainly via autophagic vesicle formation with LC3 processing, whereas lipophilic statins evoked SMC apoptosis. Cell death following 7‐ketocholesterol and low statin concentrations were not additive, presumably because the autophagic process interfered with statin‐induced caspase activation. This further illustrates that drug effects in normal SMCs are not necessarily predictive for activities in atherosclerotic settings.British Journal of Pharmacology (2008) 154, 1236–1246; doi:10.1038/bjp.2008.181; published online 12 May 2008Keywords
This publication has 33 references indexed in Scilit:
- Does Autophagy Contribute To Cell Death?Autophagy, 2005
- 7-Ketocholesterol Induces Protein Ubiquitination, Myelin Figure Formation, and Light Chain 3 Processing in Vascular Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- 7-Ketocholesterol induces reversible cytochrome c release in smooth muscle cells in absence of mitochondrial swellingCardiovascular Research, 2004
- Autophagy as a cell death and tumor suppressor mechanismOncogene, 2004
- Oxysterol-Induced Apoptosis of Vascular Smooth Muscle Cells is Reduced by HMG-CoA Reductase Inhibitor, PravastatinJournal of Atherosclerosis and Thrombosis, 2002
- Lessons From Sudden Coronary DeathArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- PROAPOPTOTIC EFFECT OF ATORVASTATIN ON STIMULATED RABBIT SMOOTH MUSCLE CELLSPharmacological Research, 1997
- Simvastatin Modulates the Heat Shock Response and Cytotoxicity Mediated by Oxidized LDL in Cultured Human Endothelial Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1997
- Oxysterols Induced Apoptosis in Cultured Smooth Muscle Cells through CPP32 Protease Activation and bcl-2 Protein DownregulationBiochemical and Biophysical Research Communications, 1996
- Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductaseAtherosclerosis, 1993